Jubilant Ingrevia's Stock Sees 5.34% Growth, Outperforms Sector and Sensex

Jubilant Ingrevia, a midcap pharmaceutical and drugs company, has seen a positive growth in its stock price on November 25th, 2024. The stock has gained 5.34% and is currently trading at Rs. 715.75. MarketsMOJO has given a 'Hold' call for the stock.

In terms of performance, Jubilant Ingrevia has outperformed its sector by 4.33% today. The stock has been on a consecutive gain for the last 4 days and has seen a rise of 9.45% in this period. The stock also touched an intraday high of Rs. 720.1, showing a 5.73% increase.

Moving averages for Jubilant Ingrevia are higher than the 5-day, 20-day, 100-day, and 200-day moving averages, but lower than the 50-day moving average. This indicates a positive trend for the stock.

In comparison to the Sensex performance, Jubilant Ingrevia has shown a 1-day performance of 5.13% while the Sensex has only seen a 1.44% increase. In the last month, Jubilant Ingrevia has outperformed the Sensex by 8.4%, with a 9.48% increase in its stock price.

Overall, Jubilant Ingrevia has shown a positive growth in its stock price and has outperformed its sector and the Sensex. Investors may want to consider a 'Hold' position for this midcap company.